Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Open-Label, Randomized, Proof of Concept Study Exploring Application of TrueTear™ for the Treatment of Meibomian Gland Disease

NCT03226769 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT03226769
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03226769 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Open-Label, Randomized, Proof of Concept Study Exploring Application of TrueTear™ for the Treatment of Meibomian Gland Disease
Lead sponsor
Allergan
Phase
Not applicable
Overall status
Completed
Start date
July 26, 2017
Completion date
December 12, 2017
Enrollment
57 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye syndromes, meibomian glands